Efficacy and safety of Chinese patent medicine (Kang-ai injection) as an adjuvant in the treatment of patients with hepatocellular carcinoma: a meta-analysis

References

• Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. 2020. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 1873:188314.
   PubMed Web of Science ®Google Scholar
• Bao LQ. 2007. Application of Kangai injection for the treatment of moderate and advanced primary liver cancer. J Hubei Coll Trad Chin Med. 9:54–55.
   Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424.
   PubMed Web of Science ®Google Scholar
• Cai SH. 2013. Curative effect observation of Kangai combined with chemotherapy for the treatment of advanced liver cancer. Chin Foreign Health Abstr. 10:142–143.
   Google Scholar
• Cai F, Wu CR, Zhang XY, Wan YJ, Cai X. 2017. Therapeutic effect of entecavir combined with traditional Chinese medicine injection on advanced liver cancer patients complicated with hepatitis B virus infection and impact on prognosis. Chin J Nosocomiol. 27:2916–2919.
   Google Scholar
• Cao J, Gu H, Ayi FH, Tai QW, Zhang JH. 2008. Clinical curative effect observation of Kangai injection in the treatment of primary liver cancer. China J Chin Mater Med. 33:2400–2401.
   Google Scholar
• Chen ZC. 2017. Clinical effect of Kangai injection combined with chemotherapy in the treatment of cancer-related fatigue of hepatocellular carcinoma patients. Inter J Ttranspl Hemopurif. 15:39–41.
   Google Scholar
• Cheng X, Yang J, Meng Y. 2016. Observation of advanced hepatocellular carcinoma chemotherapy effect of Kang’ai injection. China Cont Med Educ. 8:182–184.
   Google Scholar
• Cheng C, Zheng RF. 2019. Effect of Kang’ai injection combined with entericavir on antiviral effect and liver function in patients with advanced liver cancer. Clin Res. 27:124–126.
   Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. 2009. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Piñeros M, Znaor A, Bray F. 2019. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 144:1941–1953.
   PubMed Web of Science ®Google Scholar
• Fu J. 2016. Clinical observation on improving life quality of advanced liver cancer patients with the Kang’ai injection. Clin J Chin Med. 8:73–75.
   Google Scholar
• Fu H, Yang L, Liu XH, Li XB. 2009. A case-control study of Kangai injection combined with transcatheter arterial chemoembolization in the treatment of primary liver cancer. J Clin Med Pract. 13:62–65.
   Google Scholar
• He S. 2015. To analyze the clinical effect of the treatment of advanced hepatocellular carcinoma TACE joint Kangai injection. Clin J Chin Med. 7:124–125.
   Google Scholar
• Huang JM. 2018. The effect of Kangai injection on serum tumor related substances and alpha fetoprotein in patients with liver cancer. China Health Care Nutrit. 28:75.
   Google Scholar
• Huang S, Peng W, Mao D, Zhang S, Xu P, Yi P. 2019. Kangai injection, a Traditional Chinese medicine, improves efficacy and reduces toxicity of chemotherapy in advanced colorectal cancer patients: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2019:8423037.
   PubMed Web of Science ®Google Scholar
• Huang ZR, Yang AL, Wang RP, Ye YD. 2010. Clinical observation on Kang’ai injection in improving life quality of 35 patients with advanced liver cancer. Fujian J Tradit Chin Med. 41:8–9.
   Google Scholar
• Huang W, Zeng RX, Zhong H, Wang YJ, Luo Q, Chuan DM, Chen LC, Qing X, Zhang ZJ. 2014. Effects of Kangai injection combined with chemotherapy and embolization on advanced hepatocellular carcinoma and its effect on blood coagulation function and serum VEGF. J Hainan Med Univer. 20:1380–1382.
   Google Scholar
• Jackson D, White IR, Riley RD. 2012. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med. 31:3805–3820.
   PubMed Web of Science ®Google Scholar
• Jia S, Fu Y, Tao H. 2020. Trans-arterial chemoembolization combined with Jinlong capsule for advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis in a Chinese population. Pharm Biol. 58:771–784.
   PubMed Web of Science ®Google Scholar
• Jin GX, Jin S, Sun WJ, Ji HX, Liu Y. 2014. Application value of Kangai injection on advanced primary liver cancer palliative therapy. Chin J Clin Onco Rehab. 21:1468–1470.
   Google Scholar
• Kang SL, Rao ZG, Yang B. 2015. Observation of Kang’ai-injection on quality of life in patients with hepatocellular carci-noma after TACE. J Modern Onco. 23:92–94.
   Google Scholar
• Li QS, Cao SH, Xie GM, Gan YH, Ma HJ, Lu JZ, Zhang ZH. 1994. Combined traditional Chinese medicine and Western medicine. Relieving effects of Chinese herbs, ear-acupuncture and epidural morphine on postoperative pain in liver cancer. Chin Med J. 107:289–294.
   PubMed Web of Science ®Google Scholar
• Li HX, Ji YJ, Zhang SP, Gao ZS, Hu C, Jiang RL, Chen MJ, Li GC, Zhang X. 2019. Kangai injection combined with platinum-based chemotherapy for the treatment of stage III/IV non-small cell lung cancer: a meta-analysis and systematic review of 35 randomized controlled trials. J Cancer. 10:5283–5298.
   PubMed Web of Science ®Google Scholar
• Li HF, Xu Q, Shen YF, Jiang MH, Lu DB. 2017. The effect of Kang’ai injection in patients with hepatocellular carcinoma treated with TACE combined with MWA. Onco Prog. 15:515–517.
   Google Scholar
• Li D, Zhao F, Wang SG. 2017. Effect of Kangai injection combined with transcatheter arterial chemoembolization on coagulation function and serum VEGF in patients with advanced liver cancer. Modern J Integr Trad Chin West Med. 26:3375–3377.
   Google Scholar
• Lin L, Chu H. 2018. Quantifying publication bias in meta-analysis. Biometrics. 74:785–794.
   PubMed Web of Science ®Google Scholar
• Ling CQ, Fan J, Lin HS, Shen F, Xu ZY, Lin LZ, Qin SK, Zhou WP, Zhai XF, Li B, et al. 2018. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. J Integr Med. 16:236–248.
   PubMedGoogle Scholar
• Liu ZH. 2011. Clinical observation of Kang'ai injection on advanced liver cancer with chemotherapy. Guide China Med. 9:30–31.
   Google Scholar
• Liu HQ, Chen SX, Li Y, Huang RW. 2007. Clinical observation of Kang’ai-injection with TACE in 34 patients with hepatocellular carcinoma (HC). Hainan Med. J. 18:19–20.
   Google Scholar
• Liu J, Liu X, Ma J, Li K, Xu C. 2019. The clinical efficacy and safety of kanglaite adjuvant therapy in the treatment of advanced hepatocellular carcinoma: a PRISMA-compliant meta-analysis. Biosci Rep. 39:BSR20193319.
   PubMed Web of Science ®Google Scholar
• Lu YX, Huang DP, Hou NC, Qin B, Huang Y. 2007. Clinical effect observation of Kangai injection combined with TACE in the treatment of primary liver cancer. China J Chin Mater Med. 32:2655–2656.
   Google Scholar
• Lu Q, Li CL. 2018. Therapeutic efficacy and safety of Kang-ai injection combined with platinum-based doublet chemotherapy in advanced NSCLC: a meta-analysis. Life Sci. 210:9–19.
   PubMed Web of Science ®Google Scholar
• Ma L, Wang B, Long Y, Li H. 2017. Effect of traditional Chinese medicine combined with Western therapy on primary hepatic carcinoma: a systematic review with meta-analysis. Front Med. 11:191–202.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 62:1006–1012.
   PubMed Web of Science ®Google Scholar
• Ning Y. 2017. Antiviral effect analysis of entecavir combined with Kangai injection and effect on the improvement of liver function in patients with advanced liver cancer. Modern J Integr Trad Chin West Med. 26:1991–1993.
   Google Scholar
• Shi XG. 2019. The effect of Kangai injection combined with lamivudine on the therapeutic effect and liver function of patients with advanced liver cancer and HBV infection after transcatheter arterial chemoembolization. Anti-Infect Pharm. 16:513–515.
   Google Scholar
• Shi L, Lin L. 2019. The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analyses. Medicine. 98:e15987.
   PubMed Web of Science ®Google Scholar
• Shu JZ. 2013. Therapeutic effect observation of Kangai injection combined with chemotherapy for patients with moderate and advanced liver cancer. Seek Med Ask Med. 11:121–122.
   Google Scholar
• Song WX, Chen M, Cheng MJ, Zhang Z. 2014. Progress in clinical application of Kangai injection. Mod Hosp. 14:47–52.
   Google Scholar
• Song Q, Yang W, Meng Z, Wang J. 2020. Protocol for a systematic review and meta-analysis of Kang-ai injection for patients with oesophageal cancer. Medicine. 99:e22148.
   PubMedGoogle Scholar
• Sun YN. 2017. The clinical effect of Kangai injection combined with entecavir in the treatment of HBV related advanced liver cancer and its effect on liver function. Chin J Critic Care Med. 37:113–114.
   Google Scholar
• Sun ZG. 2017. Clinical observation of Kangai injection in improving the quality of life of patients with advanced liver cancer. J North Pharm. 14:29.
   Google Scholar
• Tian H, He ZK, Xu QJ. 2013. Clinical observation on 32 cases of primary liver cancer treated by Kangai injection combined with TACE. Nat Med Front China. 8:46–47.
   Google Scholar
• Tu Y. 2016. Artemisinin-A gift from traditional Chinese Medicine to the World (Nobel Lecture). Angew Chem Int Ed Engl. 55:10210–10226.
   PubMed Web of Science ®Google Scholar
• Wan YM, Li YH, Xu ZY, Wu HM, Xu Y, Yang M, Wu XN. 2018. The effect of transarterial chemoembolization in combination with Kang’ai injection on patients with intermediate stage hepatocellular carcinoma: a prospective study. Integr Cancer Ther. 17:477–485.
   PubMed Web of Science ®Google Scholar
• Wang KS. 2010. Clinical observation of Kangai injection in the treatment of moderate advanced liver cancer. China’s Naturopathy. 18:41–42.
   Google Scholar
• Wang WR. 2012. Response of Kang-ai injection in palliative treatment for advanced primary hepatocellular carcinoma. China Cancer. 21:874–876.
   Google Scholar
• Wang Z, Chen X, Lu Y, Chen F, Zhang W. 2020. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. Biosci Trends. 14:64–68.
   PubMed Web of Science ®Google Scholar
• Wang S, Long S, Wu W. 2018. Application of Traditional Chinese medicines as personalized therapy in human cancers. Am J Chin Med. 46:953–970.
   PubMed Web of Science ®Google Scholar
• Wei MQ. 2015. Research about effect of the influence of Kang’ai injection on the complement system and fibrosis state of patients with hepatic carcinoma. Pract J Cancer. 30:613–615.
   Google Scholar
• Xi SY, Minuk GY. 2018. Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma. World J Hepatol. 10:799–806.
   PubMed Web of Science ®Google Scholar
• Xue JX, Zhu ZY, Bian WH, Yao C. 2018. The Traditional Chinese medicine Kangai injection as an adjuvant method in combination with chemotherapy for the treatment of breast cancer in Chinese patients: a meta-analysis. Evid Based Complement Alternat Med. 2018:6305645.
   PubMed Web of Science ®Google Scholar
• Yang RY, Zhang HW. 2010. Effect of Kangai injection on quality of life in patients with advanced hepatic cancers. Chin J New Drug. 19:1575–1577.
   Google Scholar
• Yao X, Zhang DX, Yu CS. 2014. Curative effect observation of Kangai injection in the treatment of liver cancer with portal vein cancer-thrombus. Chin J Trad Med Sci Tech. 21:448–449.
   Google Scholar
• Yi JZ, Xie YC, Deng XH. 2008. Clinical observation on the effect of Kang’ai injection combined with transcatheter arterial chemoembolization on hepatocellular carcinoma in 36 patients. Tumor. 28:997–1000.
   Google Scholar
• Zeng X, Zhang Y, Kwong JS, Zhang C, Li S, Sun F, Niu Y, Du L. 2015. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 8:2–10.
   PubMedGoogle Scholar
• Zhang Y. 2015. The clinical effect of entecavir combined with Kangai injection in the treatment of HBV related liver cancer after transcatheter arterial chemoembolization. Modern J Integr Trad Chin West Med. 24:3363–3365.
   Google Scholar
• Zhou HM, Zhang AQ, Zhang ZH. 2011. The application research of traditional Chinese medicine combined with TACE in the treatment of primary liver cancer. China Health Industry. 8:88–89.
   Google Scholar
• Zhu HX. 2013. Clinical curative effect observation of TACE combined with Kangai injection in the treatment of advanced primary liver cancer. China Pract Med. 8:156–157.
   Google Scholar
• Zhu M, Liu X, Zhou C, Li J. 2020. Effect of sodium cantharidinate/vitamin B6 injection on survival, liver function, immune function, and quality of life in patients with hepatocellular carcinoma: protocol for a meta-analysis. Medicine. 99:e21952.
   PubMed Web of Science ®Google Scholar
• Zhu J, Yin T, Xu Y, Lu XJ. 2019. Therapeutics for advanced hepatocellular carcinoma: recent advances, current dilemma, and future directions. J Cell Physiol. 234:12122–12132.
   PubMed Web of Science ®Google Scholar